- Conditions
- Coronary Artery Disease
- Interventions
- [O-15]-Water PET Myocardial Perfusion Imaging (MPI)
- Drug
- Lead sponsor
- MedTrace Pharma A/S
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 215 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 7
- States / cities
- Iowa City, Iowa • Grand Rapids, Michigan • Rochester, Minnesota + 4 more
Source: ClinicalTrials.gov public record
Updated Feb 4, 2026 · Synced May 22, 2026, 1:34 AM EDT